Lorcaserin
- Generic Name
- Lorcaserin
- Brand Names
- -
- Drug Type
- -
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Associated Conditions
- -
- Associated Therapies
- -
Lorcaserin for Preventing Weight Gain Among Smokers
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-03-19
- Last Posted Date
- 2017-06-06
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 20
- Registration Number
- NCT02393547
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Lifestyle Modification and Lorcaserin for Weight Loss Maintenance
- First Posted Date
- 2015-03-17
- Last Posted Date
- 2018-06-11
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 137
- Registration Number
- NCT02388568
- Locations
- 🇺🇸
University of Pennsylvania Center for Weight and Eating Disorders, Philadelphia, Pennsylvania, United States
Low Level Laser Treatment (LLLT) and Lorcaserin for Weight Management
- First Posted Date
- 2014-05-02
- Last Posted Date
- 2016-11-22
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 44
- Registration Number
- NCT02129608
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Single Dose Study to Determine the Safety, Tolerability, and Pharmacokinetic Properties of Lorcaserin Hydrochloride (BELVIQ) in Obese Adolescents From 12 to 17 Years of Age
- First Posted Date
- 2013-12-30
- Last Posted Date
- 2019-09-17
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT02022956
- Locations
- 🇺🇸
Worlwide Clinical Trials, San Antonio, Texas, United States
🇺🇸Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Lorcaserin for Weight Loss Management in Patients on Antipsychotics: A Pilot Study
- First Posted Date
- 2013-10-14
- Last Posted Date
- 2014-01-30
- Target Recruit Count
- 15
- Registration Number
- NCT01962402
- Locations
- 🇺🇸
VA Long Beach, Long Beach, California, United States
Pharmacokinetic Properties of Lorcaserin in Obese or Overweight Elderly Subjects
- First Posted Date
- 2009-01-26
- Last Posted Date
- 2023-06-18
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT00828581
- Locations
- 🇺🇸
CRI Worldwide - Lourdes Hospital, Willingboro, New Jersey, United States
Pharmacokinetic Properties of Lorcaserin in Subjects With Hepatic Impairment
- First Posted Date
- 2009-01-26
- Last Posted Date
- 2019-09-12
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT00828932
- Locations
- 🇺🇸
Orlando Clinical Research Center, Orlando, Florida, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath